⌘K

Login Start Free

Home/Filings/4/0001209191-23-041139

4//SEC Filing

Zeronda Tyler 4

Accession 0001209191-23-041139

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:37 PM ET

Size

5.1 KB

Accession

0001209191-23-041139

Insider Transaction Report

Form 4

Period: 2023-06-30

VYNE Therapeutics Inc.VYNE

CHIEF FINANCIAL OFFICER

Transactions

Tax Payment
Common Stock
2023-06-30$4.10/sh−91$373→ 8,017 total

Footnotes (1)

[F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1

filerCIK 0001867033

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 4:37 PM ET
Size: 5.1 KB

View on SEC.gov